Hedley Griffiths

442 total citations
31 papers, 304 citations indexed

About

Hedley Griffiths is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, Hedley Griffiths has authored 31 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Rheumatology, 16 papers in Hematology and 9 papers in Genetics. Recurrent topics in Hedley Griffiths's work include Rheumatoid Arthritis Research and Therapies (25 papers), Autoimmune and Inflammatory Disorders Research (15 papers) and Systemic Lupus Erythematosus Research (11 papers). Hedley Griffiths is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (25 papers), Autoimmune and Inflammatory Disorders Research (15 papers) and Systemic Lupus Erythematosus Research (11 papers). Hedley Griffiths collaborates with scholars based in Australia, United States and United Kingdom. Hedley Griffiths's co-authors include Paul Bird, Kathleen Tymms, Lynden Roberts, Dave Nicholls, Geoffrey Littlejohn, Jane Zochling, Tegan Smith, Simon Burnet, James A. Scott and Mark Arnold and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Neurology Neurosurgery & Psychiatry and Annals of the Rheumatic Diseases.

In The Last Decade

Hedley Griffiths

28 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hedley Griffiths Australia	12	249	127	77	56	47	31	304
L.G. Schipper Netherlands	6	315 1.3×	120 0.9×	75 1.0×	68 1.2×	67 1.4×	13	364
D. Aletaha Austria	4	465 1.9×	208 1.6×	44 0.6×	211 3.8×	34 0.7×	4	524
Adriana Sánchez-Ortíz Mexico	8	199 0.8×	58 0.5×	28 0.4×	72 1.3×	51 1.1×	12	290
Bassel Elzorkany Egypt	8	327 1.3×	127 1.0×	15 0.2×	164 2.9×	20 0.4×	25	390
Dario Bruno Italy	8	87 0.3×	59 0.5×	54 0.7×	40 0.7×	13 0.3×	28	234
Jacqueline Nam United Kingdom	10	289 1.2×	85 0.7×	40 0.5×	33 0.6×	18 0.4×	22	310
Johan K. Wallman Sweden	14	381 1.5×	123 1.0×	18 0.2×	202 3.6×	42 0.9×	45	454
Yasumori Sobue Japan	12	174 0.7×	46 0.4×	20 0.3×	16 0.3×	24 0.5×	40	276
Małgorzata Tłustochowicz Poland	9	156 0.6×	54 0.4×	20 0.3×	87 1.6×	24 0.5×	36	248
S Forsberg Finland	6	262 1.1×	102 0.8×	39 0.5×	41 0.7×	69 1.5×	8	302

Countries citing papers authored by Hedley Griffiths

Since Specialization

Citations

This map shows the geographic impact of Hedley Griffiths's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hedley Griffiths with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hedley Griffiths more than expected).

Fields of papers citing papers by Hedley Griffiths

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hedley Griffiths. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hedley Griffiths. The network helps show where Hedley Griffiths may publish in the future.

Co-authorship network of co-authors of Hedley Griffiths

This figure shows the co-authorship network connecting the top 25 collaborators of Hedley Griffiths. A scholar is included among the top collaborators of Hedley Griffiths based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hedley Griffiths. Hedley Griffiths is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Littlejohn, Geoffrey, Catherine O’Sullivan, Tegan Smith, et al.. (2024). Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022. Clinical Rheumatology. 43(6). 1823–1832. 1 indexed citations

Deakin, Claire T., Geoffrey Littlejohn, Hedley Griffiths, et al.. (2023). Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost‐savings. Internal Medicine Journal. 54(5). 795–801. 1 indexed citations

Tymms, Kathleen, Catherine O’Sullivan, Tegan Smith, et al.. (2023). A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experience. Frontiers in Digital Health. 4. 1074931–1074931. 3 indexed citations

Alten, Rieke, Xavier Mariette, René‐Marc Flipo, et al.. (2022). Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study. Clinical Rheumatology. 41(8). 2361–2373. 14 indexed citations

Tymms, Kathleen, Belinda Butcher, Tracey L. Sletten, et al.. (2021). Prevalence of sleep disturbance and the association between poor disease control in people with ankylosing spondylitis within the Australian clinical setting (ASLEEP study): a real-world observational study using the OPAL dataset. Clinical Rheumatology. 41(4). 1105–1114. 6 indexed citations

Griffiths, Hedley, et al.. (2021). Persistence to Biologic Therapy Among Patients With Ankylosing Spondylitis: An Observational Study Using the OPAL Dataset. The Journal of Rheumatology. 49(2). 150–156. 4 indexed citations

Bird, Paul, Geoffrey Littlejohn, Belinda Butcher, et al.. (2021). Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia. Clinical Rheumatology. 41(1). 53–62. 12 indexed citations

Alten, Rieke, Xavier Mariette, René‐Marc Flipo, et al.. (2021). OP0180 IMPACT OF RF AND ANTI-CITRULLINATED PROTEIN ANTIBODY SEROSTATUS ON 2-YEAR RETENTION OF ABATACEPT IN PATIENTS WITH RA. Annals of the Rheumatic Diseases. 80. 108–108.

Griffiths, Hedley, et al.. (2021). Usability of the Certolizumab Pegol Auto-Injection Device in Australian Patients with Chronic Rheumatic Diseases: Results from a Market Research Study. Patient Preference and Adherence. Volume 15. 1469–1476.

10.

Smith, Tegan, Catherine O’Sullivan, Kathleen Tymms, et al.. (2021). POS0223 PATTERNS OF JANUS KINASE INHIBITOR CYCLING FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS IN REAL-WORLD CLINICAL PRACTICE: AN ANALYSIS OF THE OPAL DATASET. Annals of the Rheumatic Diseases. 80. 330–331. 1 indexed citations

11.

Bird, Paul, et al.. (2020). Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia. Clinical Rheumatology. 39(9). 2545–2551. 22 indexed citations

12.

Youssef, Peter, Peter Button, Matt Truman, et al.. (2019). Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset. The Journal of Rheumatology. 47(8). 1174–1181. 11 indexed citations

13.

Tymms, Kathleen, Geoff Littlejohn, Hedley Griffiths, et al.. (2018). Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors. Clinical Rheumatology. 37(6). 1617–1623. 11 indexed citations

14.

Bird, Paul, Charles Peterfy, P.J. Countryman, et al.. (2018). AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid Arthritis. International Journal of Rheumatology. 2018. 1–9. 5 indexed citations

15.

Roberts, Lynden, Kathleen Tymms, Geoffrey Littlejohn, et al.. (2017). The CEDAR Study: A Longitudinal Study of the Clinical Effects of Conventional DMARDs and Biologic DMARDs in Australian Rheumatology Practice. International Journal of Rheumatology. 2017. 1–8. 6 indexed citations

16.

Bird, Paul, Dave Nicholls, Hedley Griffiths, et al.. (2017). Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study. International Journal of Rheumatic Diseases. 20(4). 460–468. 15 indexed citations

17.

Littlejohn, Geoffrey, Lynden Roberts, Paul Bird, et al.. (2015). Patients with Rheumatoid Arthritis in the Australian OPAL Cohort Show Significant Improvement in Disease Activity over 5 Years: A Multicenter Observational Study. The Journal of Rheumatology. 42(9). 1603–1609. 12 indexed citations

18.

Brennan‐Olsen, Sharon L., et al.. (2014). Rheumatoid arthritis and incident fracture in women: a case–control study. BMC Musculoskeletal Disorders. 15(1). 13–13. 36 indexed citations

19.

Nicholls, Dave, Jane Zochling, David A. Mathers, et al.. (2013). A retrospective chart review of the use of rituximab for the treatment of rheumatoid arthritis in A ustralian rheumatology practice. International Journal of Rheumatic Diseases. 17(7). 755–761. 5 indexed citations

20.

Bird, Paul, Hedley Griffiths, Kathleen Tymms, et al.. (2013). The SMILE Study — Safety of Methotrexate in Combination with Leflunomide in Rheumatoid Arthritis. The Journal of Rheumatology. 40(3). 228–235. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact